The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Estimated Market Size Of The Neuro Immunoassay Market In 2026, And How Will Its Value Evolve By 2030?
The market size for neuro immunoassay (NIA) solutions has demonstrated robust expansion over recent years. This sector is anticipated to increase from $2.88 billion in 2025 to $3.12 billion by 2026, achieving a compound annual growth rate (CAGR) of 8.5%. Throughout the preceding period, this growth can be ascribed to factors such as the increasing requirement for accurate neurological diagnostics, the broader integration of immunoassay techniques in neuroscience investigations, the rising occurrence of neurodegenerative conditions, the enlargement of clinical and research laboratories, and an intensified focus on early disease identification and ongoing oversight.
The market size for neuro immunoassay (NIA) is set to experience substantial expansion in the coming years. It is projected to reach $4.28 billion by 2030, displaying a compound annual growth rate (CAGR) of 8.2%. The anticipated growth during this forecast period can be ascribed to the increasing integration of neuro immunoassay (NIA) with artificial intelligence (AI) for data analysis, escalating investment in biomarker discovery, the wider adoption of personalized medicine and therapeutic monitoring, the expansion of high-throughput screening platforms, and an increased demand for automated and precise immunoassay systems. Prominent trends throughout the forecast period include innovations driven by technology in assay sensitivity and specificity, progress in artificial intelligence (AI)-enabled data interpretation, advancements in multiplexed and lab-on-a-chip immunoassay systems, growing research and development focused on neuro biomarker identification, and new developments in integrated and automated neurodiagnostic platforms.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30676&type=smp
Which Factors Are Influencing The Growth Of The Neuro Immunoassay Market?
The growing occurrence of neurological conditions is anticipated to fuel the expansion of the neuro immunoassay market in the future. These disorders refer to health issues impacting the brain, spinal cord, and nerves, which hinder typical nervous system operation and result in deficits in movement, thought processes, perception, conduct, or general bodily regulation. The rising incidence of these conditions stems from detrimental lifestyle choices such as inadequate nutrition, lack of physical activity, smoking, heavy alcohol intake, and persistent stress. Neuro immunoassays are instrumental in identifying particular biomarkers within the nervous system, thereby aiding in prompt diagnosis and precise treatment for individuals with neurological ailments. For example, in April 2024, the National Institutes of Health (NIH), a US-based government agency, reported that approximately 6.9 million Americans aged 65 and above are presently affected by Alzheimer’s dementia, a number anticipated to almost double to 13.8 million by 2060. Consequently, the expanding occurrence of neurological disorders is a key impetus for the neuro immunoassay market.
How Is The Neuro Immunoassay Market Categorized Across Its Segment Groups?
The neuro immunoassay market covered in this report is segmented –
1) By Product Type: Reagents And Kits, Analyzers
2) By Technology: Radioimmunoassays (RIA), Polymerase Chain Reaction (PCR), Enzyme-Linked Immunosorbent Assay (ELISA), Western Blot, Rapid Tests, Enzyme-Linked Immunospot Assay (ELISPOT)
3) By Analyte Or Biomarker Type: Amyloid-Beta (Aß), Tau Protein (p-Tau), Alpha-Synuclein (a-syn), Neurofilament Light Chain (NfL), Autoantibodies, Cytokines, Glial Fibrillary Acidic Protein (GFAP), Neuron-Specific Enolase (NSE), Ubiquitin C-Terminal Hydrolase L1 (UCH-L1), Brain-Derived Neurotrophic Factor (BDNF)
4) By Application: Alzheimer’s Disease, Parkinson’s Disease (PD), Huntington’s Disease, Amyotrophic Lateral Sclerosis (ALS), Spinal Muscular Atrophy (SMA)
5) By End-User: Hospitals, Clinics, Academic Organizations, Biopharmaceutical Companies, Pharmaceutical Companies, Other End-Users
Subsegments:
1) By Reagents And Kits: Enzyme Linked Immunosorbent Assay Reagents, Western Blotting Kits, Multiplex Assay Kits
2) By Analyzers: Automated Immunoassay Analysers, Point Of Care Immunoassay Analysers, High Throughput Immunoassay Analysers
Which Trends Are Influencing Demand In The Neuro Immunoassay Market?
Major companies operating in the neuro immunoassay market are concentrating on developing advanced solutions, such as blood-based neurological biomarker assays, to improve disease monitoring, enhance prognostic accuracy, and support clinical decision-making for neurological disorders. Blood-based neurological biomarker assays are defined as tests that measure specific proteins, like Neurofilament Light Chain (NfL), within human serum or plasma to evaluate neuronal injury and disease activity. For instance, in June 2024, Siemens Healthineers, a Germany-based in vitro diagnostics company, obtained CE marking for its Neurofilament Light Chain blood test, intended for use on the Atellica IM Analyzer and ADVIA Centaur systems. This test quantifies NfL levels to assist in predicting neuronal injury risk in adults with relapsing multiple sclerosis, acting as a complement to clinical, imaging, and laboratory assessments, and the CE mark confirms compliance with European In Vitro Diagnostic Regulations, thereby extending access to standardized neuro immunoassay diagnostics across European laboratories.
Which Firms Are Influencing Competition In The Neuro Immunoassay Market?
Major companies operating in the neuro immunoassay market are Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories Inc., GenScript Biotech Corporation, Abcam plc, BioLegend Inc., Meso Scale Diagnostics LLC, Sino Biological Inc., Quanterix Corporation, Cusabio Technology LLC, OriGene Technologies Inc., Elabscience Biotechnology Inc., RayBiotech Life Inc., Enzo Life Sciences Inc., Rockland Immunochemicals Inc., Assay Genie Ltd., Novus Biologicals LLC, Creative Diagnostics, MyBioSource Inc., Immuno-Biological Laboratories Co. Ltd., Boster Biological Technology, Cloud-Clone Corp., FineTest Biotech Inc., Abbexa Ltd.
Get The Full Neuro Immunoassay Market Report:
https://www.thebusinessresearchcompany.com/report/neuro-immunoassay-market-report
Where Is The Neuro Immunoassay Market Primarily Concentrated By Region?
North America was the largest region in the neuro immunoassay (NIA) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuro immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Neuro Immunoassay Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=30676&type=smp
Browse Through More Reports Similar to the Global Neuro Immunoassay Market 2026, By The Business Research Company
Immunoassay Market Report 2026
https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report
Immunohematology Market Report 2026
https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report
immunomodulator global market report
https://www.thebusinessresearchcompany.com/report/immunomodulator-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model